This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Mar;11(3):281-3.

doi: 10.1016/j.jtho.2016.01.005.

Laying the Groundwork to Confront the Final Frontier of CNS Metastasis in NSCLC with Targetable Driver Mutations

Thanyanan Reungwetwattana¹, Sai-Hong Ignatius Ou²

Affiliations

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Ratchatewi, Bangkok, Thailand.
² Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, California. Electronic address: ignatius.ou@uci.edu.

PMID: 26922919
DOI: 10.1016/j.jtho.2016.01.005

Free article

Editorial

Laying the Groundwork to Confront the Final Frontier of CNS Metastasis in NSCLC with Targetable Driver Mutations

Thanyanan Reungwetwattana et al. J Thorac Oncol. 2016 Mar.

Free article

. 2016 Mar;11(3):281-3.

doi: 10.1016/j.jtho.2016.01.005.

Authors

Thanyanan Reungwetwattana¹, Sai-Hong Ignatius Ou²

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Ratchatewi, Bangkok, Thailand.
² Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, California. Electronic address: ignatius.ou@uci.edu.

PMID: 26922919
DOI: 10.1016/j.jtho.2016.01.005

No abstract available

PubMed Disclaimer

Comment on

First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases.
Schuler M, Wu YL, Hirsh V, O'Byrne K, Yamamoto N, Mok T, Popat S, Sequist LV, Massey D, Zazulina V, Yang JC. Schuler M, et al. J Thorac Oncol. 2016 Mar;11(3):380-90. doi: 10.1016/j.jtho.2015.11.014. Epub 2016 Jan 25. J Thorac Oncol. 2016. PMID: 26823294 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information